Clinical trial

Convalescent Plasma as Adjunct Therapy for COVID-19

NCT04873414

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2020-12-01

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2020-12-01Date precision: day

Registry last updated2021-06-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COVID-19unresolved

Interventions

Convalescent plasma treatmentBIOLOGICAL

Sponsors & collaborators

National Institute of Health Research and Development, Ministry of Health Republic of Indonesialead sponsor

Indonesian Red Crosscollaborator

Eijkman Institute for Molecular Biologycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04873414 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.